Symptomatic hypocalcemia after tocolytic therapy with magnesium sulfate and nifedipine
- 1 June 2004
- journal article
- case report
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 190 (6) , 1773-1776
- https://doi.org/10.1016/j.ajog.2004.02.050
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Symptomatic hypocalcaemia in hypermagnesaemia-induced hypoparathyroidism, during magnesium tocolytic therapy--possible involvement of the calcium-sensing receptor.Nephrology Dialysis Transplantation, 1999
- Long-Term Magnesium Sulfate Tocolysis and Maternal Osteoporosis in a Triplet Pregnancy: A Case ReportAmerican Journal of Perinatology, 1998
- Analysis of the Risks Associated With Calcium Channel BlockadeObstetrical & Gynecological Survey, 1997
- Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergenciesAmerican Journal of Obstetrics and Gynecology, 1996
- The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockadeBJOG: An International Journal of Obstetrics and Gynaecology, 1994
- Calcium homeostasis in pregnant women receiving long-term magnesium sulfate therapy for preterm laborAmerican Journal of Obstetrics and Gynecology, 1992
- Neuromuscular blockade with magnesium sulfate and nifedipineAmerican Journal of Obstetrics and Gynecology, 1989
- Tetany Associated with NifedipineNew England Journal of Medicine, 1986
- The Influence of Hypermagnesemia on Serum Calcium and Parathyroid Hormone Levels in Human SubjectsNew England Journal of Medicine, 1984
- Effects of magnesium sulfate treatment on perinatal calcium metabolismAmerican Journal of Obstetrics and Gynecology, 1979